Skip to main content
SpringerLink
Log in

Polymyalgia rheumatica and giant cell arteritis

  • Chapter
Prognosis in the Rheumatic Diseases

  • 126 Accesses

Abstract

The prognosis of polymyalgia rheumatica can be described as excellent. Patients respond promptly to prednisone and, with rare exceptions, the disease can be suppressed with a small, safe dose of 5 mg a day. While it may be necessary to continue this medication for years, the natural history is one of eventual remission without residual joint damage.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bagratuni, L. (1963). Prognosis in the anarthritic rheumatoid syndrome Br. Med. J., 1, 513–518.

    Article  PubMed  CAS  Google Scholar 

  2. Douglas, W. A. C., Martin, B. A. and Morris, J. H. (1983). Polymyalgia rheumatica: an arthroscopic study of the shoulder joint. Ann. Rheum. Dis., 42, 311–316.

    Article  PubMed  CAS  Google Scholar 

  3. Chou, C. T. and Schumacher, H. R. (1984). Clinical and pathologic studies of synovitis in polymyalgia rheumatica. Arthritis Rheum., 27, 1107–1118.

    Article  PubMed  CAS  Google Scholar 

  4. Von Knorring, J. and Somer, T. (1974). Malignancy in association with polymyalgia rheumatica and temporal arteritis. Scand. J. Rheumatol, 3, 129–135.

    Article  Google Scholar 

  5. Chuang, T. Y., Hunder, G. G., Ilstrup, D. M. and Kurland, L. T. (1982). Polymyalgia rheumatica. A 10-year epidemiologic and clinical study. Ann. Intern. Med., 97, 672–680.

    PubMed  CAS  Google Scholar 

  6. Haley, L. A. (1984). Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin. Arthritis Rheum., 13, 322–328.

    Article  Google Scholar 

  7. Plotz, C. M. and Spiera, H. (1969). Polymyalgia rheumatica. Bull. Rheum. Dis., 20, 578–581.

    PubMed  CAS  Google Scholar 

  8. Coomes, E. N., Ellis, R. M. and Kay, A. G. (1976). A prospective study of 102 patients with polymyalgia rheumatica syndrome. Rheumatol. Rehabil., 15, 270–276.

    Article  PubMed  CAS  Google Scholar 

  9. Behn, A. R., Perera, T. and Myles, A. B. (1983). Polymyalgia rheumatica and corticosteroids: How much for how long? Ann. Rheum. Dis., 42, 374–378.

    Article  PubMed  CAS  Google Scholar 

  10. Kyle, V. and Hazelman, B. L. (1990). Stopping steroids in polymyalgia rheumatica and giant cell arteritis. Br. Med. J., 300, 344–345.

    Article  CAS  Google Scholar 

  11. Von Knorring, J. (1979). Treatment and prognosis in polymyalgia rheumatica and giant cell arteritis. A ten-year survey of 53 patients. Acta Med. Scand., 205, 429–435.

    Article  Google Scholar 

  12. Ayoub, W. T., Franklin, C. M. and Torretti, D. (1985). Polymyalgia rheumatica. Duration of therapy and long-term outcome. Am. J. Med., 79, 309–315.

    Article  PubMed  CAS  Google Scholar 

  13. Hamrin, B. (1972). Polymyalgia arteritica. Acta Med. Scand., Suppl. 533, 1–164.

    CAS  Google Scholar 

  14. Salvarani, C. et al. (1987). Synovitis in polymyalgia rheumatica: A 5-year follow up study in Reggio Emilia, Italy. (Letter.) J. Rheumatol., 14, 1209–1210.

    PubMed  CAS  Google Scholar 

  15. Myles, A. B. (1975). Polymyalgia rheumatica and giant cell arteritis: A seven-year survey. Rheumatol. Rehabil., 14, 231–235.

    Article  PubMed  CAS  Google Scholar 

  16. Kyle, V., Tudor, J., Wraight, E. P., Gresham, G. A. and Hazelman, B. L. (1990). Rarity of synovitis in polymyalgia rheumatica. Ann. Rheum. Dis., 49, 155–157.

    Article  PubMed  CAS  Google Scholar 

  17. Arnett, F. C. et al. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum., 31, 315–324.

    Article  PubMed  CAS  Google Scholar 

  18. Healey, L. A. and Sheets, P. K. (1988). The relation of polymyalgia rheumatica to rheumatoid arthritis. J. Rheumatol., 15, 750–752.

    PubMed  CAS  Google Scholar 

  19. Nepom, G. T. et al. (1989). HLA genes associated with rheumatoid arthritis. Arthritis Rheum., 32, 15–21.

    Article  PubMed  CAS  Google Scholar 

  20. Hall, S. B., Ginsburg, W. W., Vollersten, R. S. and Hunder, G. G. (1983). The coexistence of rheumatoid arthritis and giant cell arteritis. J. Rheumatol., 10, 995–997.

    PubMed  CAS  Google Scholar 

  21. Bengtsson, B. A. (1990). Giant cell arteritis. Curr. Opinion Rheum., 2, 60–65.

    Article  CAS  Google Scholar 

  22. Healey, L. A. (1986). The relationship of polymyalgia rheumatica to giant cell arteritis — single or separate syndromes? (Letter.) J. Rheumatol., 13, 1190.

    PubMed  CAS  Google Scholar 

  23. Jones, J. G. and Hazelman, B. L. (1981). Prognosis and management of polymyalgia rheumatica. Ann. Rheum. Dis., 40, 1–5.

    Article  PubMed  CAS  Google Scholar 

  24. Caselli, R. J., Hunder, G. G. and Whisnant, J. P. (1988). Neurologic disease in biopsyproven giant cell (temporal) arteritis. Neurology, 38, 352–359.

    Article  PubMed  CAS  Google Scholar 

  25. Wilkinson, I. M. S. and Russell, R. W. R. (1972). Arteries of the head and neck in giant cell arteritis. Arch. Neurol, 27, 378–391.

    Article  PubMed  CAS  Google Scholar 

  26. Save-Soderbergh, J., Malmvall, B. E., Andersson, R. and Bengtsson, B. A. (1986). Giant cell arteritis as a cause of death. J. Am. Med. Assoc, 255, 493–496.

    Article  CAS  Google Scholar 

  27. Andersson, R., Malmvall, B. E. and Bengtsson, B. A. (1986). Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Acta Med. Scand., 220, 361–364.

    Article  PubMed  CAS  Google Scholar 

  28. Huston, K. A., Hunder, G. G., Lie, J. T., Kennedy, R. H. and Elveback, L. R. (1978). Temporal arteritis: A 25 year epidemiologic, clinical and pathologic study. Ann. Intern. Med., 88, 162–167.

    PubMed  CAS  Google Scholar 

  29. Nordborg, E. and Bengtsson, B. A. (1989). Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. Br. Med. J., 299, 549–550.

    Article  CAS  Google Scholar 

  30. Healey, L. A. and Wilske, K. R. (1977). Manifestations of giant cell arteritis. Med. Clin. North Am., 61, 261–270.

    PubMed  CAS  Google Scholar 

  31. Caselli, R. J., Daube, J. R., Hunder, G. G. and Whisnant, J. P. (1988). Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology, 38, 685–689.

    Article  PubMed  CAS  Google Scholar 

  32. Calamia, K. T. and Hunder, G. G. (1980). Clinical manifestations of giant cell (temporal) arteritis. Clin. Rheum. Dis., 6, 389–403.

    Google Scholar 

  33. Andersson, R., Malmvall, B. E. and Bengtsson, B. A. (1986). Long-term treatment in giant cell arteritis. Acta Med. Scand., 220, 465–469.

    Article  PubMed  CAS  Google Scholar 

  34. Rosenfeld, S. J., Kosmorsky, G. S., Klingele, T. G., Burde, R. M. and Cohn, E. M. (1986). Treatment of temporal arteritis with ocular involvement. Am. J. Med., 80, 143–145.

    Article  PubMed  CAS  Google Scholar 

  35. Horton, B. T. and Magath, T. B. (1937). Arteritis of the temporal vessels: Report of seven cases. Proc. Staff Meet. Mayo Clin., 12, 548–553

    Google Scholar 

Download references

Authors
  1. L. A. Healey
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Western Ontario, London, Ontario, Canada

    Nicholas Bellamy MD, MSc, FRCP(Glas), FRCP(Edin), FRCP(C), FACP (Associate Professor of Medicine, Epidemiology and Biostatistics, Director) (Associate Professor of Medicine, Epidemiology and Biostatistics, Director)

  2. Division of Rheumatology, Victoria Hospital, London, Ontario, Canada

    Nicholas Bellamy MD, MSc, FRCP(Glas), FRCP(Edin), FRCP(C), FACP (Associate Professor of Medicine, Epidemiology and Biostatistics, Director) (Associate Professor of Medicine, Epidemiology and Biostatistics, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Healey, L.A. (1991). Polymyalgia rheumatica and giant cell arteritis. In: Bellamy, N. (eds) Prognosis in the Rheumatic Diseases. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3896-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3896-3_13

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5735-6

  • Online ISBN: 978-94-011-3896-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation